11,633 results
Search Results
2. Ethanol and MDMA: a comment on the paper by Dumont et al.
3. Ethanol and MDMA: a comment on the paper by Izco et al.
4. Awards given to most frequently cited papers in Psychopharmacology
5. Comment on the paper by Horowski and Dorow
6. Response to paper by Kelly et al "The opioid receptor pharmacology of GSK1521498 compared to other ligands with different effects on compulsive reward-related behaviors" published in Psychopharmacology 232, 305-314, 2014.
7. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents
8. Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis.
9. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.
10. The effect of methylphenidate and mixed amphetamine salts on cognitive reflection: a field study.
11. The secondary visual cortex mediated the enhancement of associative learning on methamphetamine self-administration behaviors.
12. Gut microbiota connects the brain and the heart: potential mechanisms and clinical implications.
13. Chronic REM sleep deprivation leads to manic- and OCD-related behaviors, and decreases hippocampal BDNF expression in female rats.
14. Sex differences in effort-related decision-making: role of dopamine D2 receptor antagonism.
15. Measuring impulsivity in mice: the five-choice serial reaction time task
16. 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?
17. Roger Russell: 1914–1998
18. Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD
19. Kappa opioids and the modulation of pain
20. Behavioral effects of modafinil in marmoset monkeys
21. The origin of pharmacopsychology: Emil Kraepelin’s experiments in Leipzig, Dorpat and Heidelberg (1882–1892)
22. Improved multiparameter models of drug effects on response rate under multiple variable interval schedules: evidence from rat studies
23. Interactions of Ro15-4513, Ro15-1788 (flumazenil) and ethanol on measures of exploration and locomotion in rats
24. Ethanol self-administration in freely feeding and drinking rats: effects of Ro15-4513 alone, and in combination with Ro15-1788 (flumazenil)
25. Cigarette smoking, blood lipids, and baroreceptor-modulated nociception
26. Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain
27. The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.
28. Nicotine addiction: a re-analysis of the arguments
29. Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
30. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise
31. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine
32. On the measurement of the effects of alcohol and illicit substances on inhibition of return
33. Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction
34. Living in the here and now: interrelationships between impulsivity, mindfulness, and alcohol misuse
35. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action
36. Elevated gray and white matter densities in cocaine abstainers compared to current users
37. Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA
38. Effects of stress on alcohol drinking: a review of animal studies
39. ELAV–GAP43 pathway activation following combined exposure to cocaine and stress
40. Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder
41. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and d-amphetamine models of schizophrenia
42. High impulsivity predicting vulnerability to cocaine addiction in rats: some relationship with novelty preference but not novelty reactivity, anxiety or stress
43. Gene–environment interactions: early life stress and risk for depressive and anxiety disorders
44. Early-life stress and cognitive outcome
45. Genetics of caffeine consumption and responses to caffeine
46. Light and intermittent cigarette smokers: a review (1989–2009)
47. The 5-HT7 receptor and disorders of the nervous system: an overview
48. Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
49. Effects of yohimbine and hydrocortisone on panic symptoms, autonomic responses, and attention to threat in healthy adults
50. Lithium and cognitive enhancement: leave it or take it?
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.